Comparative Lipophilicity of Morphine Derivatives

被引:2
|
作者
Kalasz, Huba [1 ]
Dolezal, Rafael [2 ]
Tekes, Kornelia [3 ]
Magyar, Kalman [3 ]
Csermely, Tamas [1 ]
Hosztafi, Sandor [4 ]
机构
[1] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1089 Budapest, Hungary
[2] Univ Hosp, Hradec Kralove 50005, Czech Republic
[3] Semmelweis Univ, Dept Pharmacodynam, H-1089 Budapest, Hungary
[4] Dept Pharmaceut Chem, H-1092 Budapest, Hungary
关键词
Morphine; Morphine derivatives; Lipophilicity; Reversed-phase thin-layer chromatography; R-M values; Immobilized artificial membrane column; PERFORMANCE LIQUID-CHROMATOGRAPHY; THIN-LAYER CHROMATOGRAPHY; MEDICINAL CHEMISTRY; INTERCEPT; DRUGS; SLOPE;
D O I
10.1556/JPC.28.2015.2.7
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Lipophilicity is an important physicochemical characteristic of compounds having potential use in the treatment of humans and animals. Morphine and its semisynthetic derivatives have effects on mu (mu), kappa (kappa), and delta (delta) opioid receptors, and their physiological, pharmacological, and therapeutic effects mainly depend on their distribution in the body. The progress in separation techniques has made it possible to use modern methods to determine lipophilic/hydrophilic character of small amounts of organic compounds in just a few minutes. In addition to the classical determination of lipophilicity (shaken-flask method), other experimental methods (such as reversed-phase thin-layer chromatography, distribution-pH profile, etc.) and calculations based on the molecular composition are widely used. The lipophilic character of several morphine derivatives was determined using reversed-phase thin-layer chromatography and also high-performance liquid chromatography (HPLC) method. The results are graphically compared. Lipophilicity (log P) calculation using Pallas 3.8 program was successful only for certain morphine derivatives. Parameters derived from the experimental results of reversed-phase thin-layer chromatography and those of a special HPLC column were well comparable.
引用
收藏
页码:126 / 132
页数:7
相关论文
共 50 条
  • [21] Synthesis and Evaluation of Ivacaftor Derivatives with Reduced Lipophilicity
    Iazzi, Melissa
    Junor, Phillip
    Doshi, Jitesh
    Acharya, Saujanya
    Suhring, Roxana
    Viirre, Russell D.
    Gupta, Gagan D.
    ACS OMEGA, 2023, 8 (48): : 45606 - 45615
  • [22] Chromatographic behaviour and lipophilicity of some benzimidazole derivatives
    Perisic-Janjic, NU
    Podunavac-Kuzmanovic, SO
    Balaz, JS
    Vlaovic, D
    JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2000, 13 (02) : 123 - 129
  • [23] NEW MORPHINE DERIVATIVES
    PAPAIOANNOU, G
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1976, 11 (03) : 287 - 287
  • [24] Calculation procedures for molecular lipophilicity: A comparative study
    Mannhold, R
    Dross, K
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1996, 15 (05): : 403 - 409
  • [25] The study of the lipophilicity of some aminoalkanol derivatives with anticonvulsant activity
    Waszkielewicz, Anna
    Szkaradek, Natalia
    Pekala, Elzbieta
    Galzarano, Fabiola
    Marona, Henryk
    BIOMEDICAL CHROMATOGRAPHY, 2010, 24 (12) : 1365 - 1372
  • [26] Lipophilicity study of some antipyrine derivatives and their interaction with aminoacids
    Sahini, VE
    Caproiu, MT
    Ionita, G
    REVUE ROUMAINE DE CHIMIE, 1999, 44 (09) : 817 - 822
  • [27] The influence of structure and lipophilicity of hydantoin derivatives on anticonvulsant activity
    Scholl, S
    Koch, A
    Henning, D
    Kempter, G
    Kleinpeter, E
    STRUCTURAL CHEMISTRY, 1999, 10 (05) : 355 - 366
  • [28] Investigation of lipophilicity of anticancer-active thioquinoline derivatives
    Bajda, Marek
    Boryczka, Stanislaw
    Wietrzyk, Joanna
    Malawska, Barbara
    BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (02) : 123 - 131
  • [29] MODELING OF CHROMATOGRAPHIC LIPOPHILICITY INDICES OF BILE ACIDS AND THEIR DERIVATIVES
    Onisor, Cristina
    Posa, Mihalj
    Sarbu, Costel
    REVUE ROUMAINE DE CHIMIE, 2011, 56 (03) : 217 - +
  • [30] Lipophilicity studies on beta-blocker benzoxazinone derivatives
    Panderi, I
    Angelopoulos, C
    TsantiliKakoulidou, A
    Kazanis, M
    Vavayannis, A
    FARMACO, 1997, 52 (03): : 167 - 172